1. J Hepatol. 2019 Aug;71(2):434-438. doi: 10.1016/j.jhep.2019.04.008. Epub 2019 
May 8.

Convalescent plasma therapy for persistent hepatitis E virus infection.

Ankcorn M(1), Gallacher J(2), Ijaz S(3), Taha Y(4), Harvala H(5), Maclennan 
S(6), Thomson EC(7), Davis C(7), Singer JB(7), da Silva Filipe A(7), Smollett 
K(7), Niebel M(7), Semple MG(8), Tedder RS(9), McPherson S(10).

Author information:
(1)Blood Borne Virus Unit, Virus Reference Department, National Infection 
Service, Public Health England, Colindale, London, UK; Transfusion Microbiology, 
National Health Service Blood and Transplant, London, UK. Electronic address: 
michaelankcorn@nhs.net.
(2)Liver Unit, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation 
Trust, Newcastle, UK.
(3)Blood Borne Virus Unit, Virus Reference Department, National Infection 
Service, Public Health England, Colindale, London, UK.
(4)Departments of Virology and Infectious Diseases, Newcastle upon Tyne 
Hospitals NHS Foundation Trust, Newcastle, UK.
(5)Transfusion Microbiology, National Health Service Blood and Transplant, 
London, UK.
(6)Transfusion Medicine, National Health Service Blood and Transplant, Leeds, 
UK.
(7)MRC-University of Glasgow Centre for Virus Research, Glasgow, UK.
(8)Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
(9)Blood Borne Virus Unit, Virus Reference Department, National Infection 
Service, Public Health England, Colindale, London, UK; Transfusion Microbiology, 
National Health Service Blood and Transplant, London, UK; Department of 
Medicine, Imperial College London, London, UK.
(10)Liver Unit, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation 
Trust, Newcastle, UK; Institute of Cellular Medicine, Faculty of Medical 
Sciences, Newcastle University, UK. Electronic address: 
stuart.mcpherson@nuth.nhs.uk.

DOI: 10.1016/j.jhep.2019.04.008
PMCID: PMC7126959
PMID: 31075322 [Indexed for MEDLINE]